Du är här


DSM N.V. : Final dividend Royal DSM

The DSM Annual General Meeting of Shareholders on 7 May 2014 passed a
resolution to declare a dividend for 2013 of €1.65 per ordinary share of
€1.50 par value. An interim dividend of €0.50 per ordinary share having been
paid on 29 August 2013, the final dividend for 2013 will amount to €1.15 per
ordinary share.
With the passing of the resolution by the AGM, and in line with DSM's policy
to provide a stable and preferably rising dividend, 2013 marks the fourth
consecutive year DSM's dividend has been increased.

This final dividend of €1.15 will be paid out in cash or in the form of
ordinary shares at the option of the shareholder. Dividend in cash will be
paid after deduction of 15% Dutch dividend withholding tax. The ex-dividend
date on NYSE Euronext will be 9 May 2014 and the record date will be 13 May

Shareholders have from 14 May until 27 May 2014 (3.00 pm CET) to indicate
their choice. On 28 May 2014 after the close of trading on NYSE Euronext the
number of dividend rights of ordinary shares entitling the holder to one
ordinary share will be determined.

This exchange ratio will be based on the volume weighted average price of all
ordinary shares in DSM traded at NYSE Euronext on 21 May 2014 up to and
including 27 May 2014. The value of the stock dividend will be virtually
equal to the value of the cash dividend. The ordinary shares that constitute
the stock dividend are entitled to any dividend for the financial year 2014
and to the dividends for subsequent financial years. Stock dividend rights
will not be traded on NYSE Euronext.

The following timetable applies:
9 May 2014: Ex-dividend
13 May 2014: Record Date
14 May 2014 - 27 May 2014(3.00 pm CET): Period in which shareholders
can indicate their choice
28 May 2014 (COB): Announcement of
the exchange ratio
3 June 2014: Delivery of
shares or cash payment

DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and
Materials Sciences DSM is driving economic prosperity, environmental progress
and social advances to create sustainable value for all stakeholders
simultaneously. DSM delivers innovative solutions that nourish, protect and
improve performance in global markets such as food and dietary supplements,
personal care, feed, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials.
DSM's 24,500 employees deliver annual net sales of around €10 billion. The
company is listed on NYSE Euronext. More information can be found

Or find us on:

For more information:

|DSM Corporate CommunicationsHerman Betten DSM Investor RelationsDave Huizing |
|tel. +31 (0) 455782017 |
|e-mailmedia.contacts@dsm.com tel. +31 (0) 45 5782864 |
| e-mailinvestor.relations@dsm.com |
Press release-pdf


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.